138 related articles for article (PubMed ID: 11049978)
1. Induction of B-cell tolerance by retroviral gene therapy.
Bracy JL; Iacomini J
Blood; 2000 Nov; 96(9):3008-15. PubMed ID: 11049978
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of xenoreactive natural antibody production by retroviral gene therapy.
Bracy JL; Sachs DH; Iacomini J
Science; 1998 Sep; 281(5384):1845-7. PubMed ID: 9743496
[TBL] [Abstract][Full Text] [Related]
3. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.
Cretin N; Bracy J; Hanson K; Iacomini J
J Immunol; 2002 Feb; 168(3):1479-83. PubMed ID: 11801692
[TBL] [Abstract][Full Text] [Related]
4. Induction of molecular chimerism by gene therapy prevents antibody-mediated heart transplant rejection.
Bracy JL; Chase CM; Russell PS; Mauiyyedi S; Colvin RB; Iacomini J
Gene Ther; 2001 Nov; 8(22):1738-44. PubMed ID: 11892842
[TBL] [Abstract][Full Text] [Related]
5. Engraftment of genetically modified bone marrow cells in sensitized hosts.
Bracy J; Iacomini J
Mol Ther; 2002 Aug; 6(2):252-7. PubMed ID: 12161192
[TBL] [Abstract][Full Text] [Related]
6. High antigen levels do not preclude B-cell tolerance induction to alpha1,3-Gal via mixed chimerism.
Haspot F; Bardwell PD; Zhao G; Sykes M
Xenotransplantation; 2008; 15(5):313-20. PubMed ID: 19134161
[TBL] [Abstract][Full Text] [Related]
7. Fetal porcine thymus engraftment, survival and CD4 reconstitution in alphaGal-KO mice is impaired in the presence of high levels of antibodies against alphaGal.
Rodriguez-Barbosa JI; Zhao Y; Houser S; Zhao G; Sykes M
Xenotransplantation; 2003 Jan; 10(1):24-40. PubMed ID: 12535223
[TBL] [Abstract][Full Text] [Related]
8. Xenotransplantation and ABO incompatible transplantation: the similarities they share.
Galili U
Transfus Apher Sci; 2006 Aug; 35(1):45-58. PubMed ID: 16905361
[TBL] [Abstract][Full Text] [Related]
9. Tolerance induction by lentiviral gene therapy with a nonmyeloablative regimen.
Mitsuhashi N; Fischer-Lougheed J; Shulkin I; Kleihauer A; Kohn DB; Weinberg KI; Starnes VA; Kearns-Jonker M
Blood; 2006 Mar; 107(6):2286-93. PubMed ID: 16291598
[TBL] [Abstract][Full Text] [Related]
10. The role of complement receptors in production of antibodies specific for Galalpha1,3Gal.
Kaye J; Bagley J; Malkowski D; Iacomini J
Transplantation; 2004 Jan; 77(2):314-6. PubMed ID: 14743001
[TBL] [Abstract][Full Text] [Related]
11. The influence of natural antibody specificity on antigen immunogenicity.
Benatuil L; Kaye J; Rich RF; Fishman JA; Green WR; Iacomini J
Eur J Immunol; 2005 Sep; 35(9):2638-47. PubMed ID: 16082726
[TBL] [Abstract][Full Text] [Related]
12. Immunoglobulin heavy chain transgenic mice expressing Galalpha(1,3)Gal-reactive antibodies.
Cretin N; Iacomini J
Transplantation; 2002 May; 73(10):1558-64. PubMed ID: 12042640
[TBL] [Abstract][Full Text] [Related]
13. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Mohiuddin MM; Ogawa H; Yin DP; Galili U
Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
[TBL] [Abstract][Full Text] [Related]
14. Anti-Gal(alpha)1-3Gal antibody response to porcine bone marrow in unmodified baboons and baboons conditioned for tolerance induction.
Kozlowski T; Monroy R; Xu Y; Glaser R; Awwad M; Cooper DK; Sachs DH
Transplantation; 1998 Jul; 66(2):176-82. PubMed ID: 9701260
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and limitations of cyclophosphamide-induced tolerance against alphaGal antigen.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Sueishi K; Nomoto K; Yasui H
Scand J Immunol; 2005 Sep; 62(3):271-80. PubMed ID: 16179014
[TBL] [Abstract][Full Text] [Related]
16. Sequential analysis of anti-alpha Gal natural antibody-producing B cells in GalT knockout mice in cyclophosphamide-induced tolerance.
Shimizu I; Tomita Y; Iwai T; Kajiwara T; Okano S; Nomoto K; Tominaga R
Scand J Immunol; 2006 Jun; 63(6):435-43. PubMed ID: 16764697
[TBL] [Abstract][Full Text] [Related]
17. Intragraft gene expression profile associated with the induction of tolerance.
Doki T; Mello M; Mock D; Evans JM; Kearns-Jonker M
BMC Immunol; 2008 Feb; 9():5. PubMed ID: 18267024
[TBL] [Abstract][Full Text] [Related]
18. Complement insufficiency limits efficacy in a xenograft model of hyperacute rejection for cancer therapy.
Larkin JM; Porter CD
Cancer Immunol Immunother; 2007 Jan; 56(1):60-9. PubMed ID: 16715304
[TBL] [Abstract][Full Text] [Related]
19. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
[TBL] [Abstract][Full Text] [Related]
20. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
